Company performance
Current Price
as of Jan 21, 2025$34.00
P/E Ratio
N/A
Market Cap
$297.2M
- DWSN
Description
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Metrics
Overview
- HQFort Worth, TX
- SectorHealth Technology
- IndustryMedical Specialties
- TickerSMTI
- Price$34+4.17%
Trading Information
- Market cap$297.20M
- Float34.64%
- Average Daily Volume (1m)26,318
- Average Daily Volume (3m)31,363
- EPS-$0.99
Company
- Revenue$78.06M
- Rev growth (1yr)35.24%
- Net income-$2.86M
- Gross margin85.71%
- EBITDA margin-3.11%
- EBITDA-$0.67M
- EV$272.88M
- EV/Revenue3.50
- P/EN/A
- P/S3.71
- P/B7.47
Documents
SEC Filings
Earnings Calls
Factset Street Account